Rephonic
Artwork for Prostate Cancer Update

Prostate Cancer Update

Dr. Neil Love
Prostate Cancer
Urothelial Bladder Cancer
Pembrolizumab
Immunotherapy
Renal Cell Carcinoma
Clinical Trials
Urethral Bladder Cancer
PARP Inhibitors
Metastatic Urothelial Bladder Cancer
Hormonal Therapy
Androgen Receptor Pathway Inhibitors
AKT Inhibitors
EMBARQ Study
Chemotherapy
Tar-200
Bladder Cancer
Antibody-Drug Conjugates
Circulating Tumor DNA
HER2
P10 Deficiency

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.

PublishesDailyEpisodes178Founded20 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Prostate Cancer Update

Latest Episodes

Featuring perspectives from Dr William K Oh and Dr Mary-Ellen Taplin, including the following topics:

• Introduction: Another Perspective on the Treatment of Localized Prostate Cancer (0:00)

• Nonmetastatic Disease (10:32)

• Metastatic Androgen Path... more

YouTube

Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:

• Tolerability of capivasertib and management of associated side effects — Question from Neeraj Agarwal, M... more

Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics:

• Introduction (0:00)

• Overview of Prostate Cancer (3:00)

• Hormonal Therapy for Nonmetastati... more

YouTube

Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:

• Case: A patient with T4 disease, pelvic wall involvement and a positive pel... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Lung Cancer Update
Lung Cancer UpdateDr. Neil Love
Plenary Session
Plenary SessionVinay Prasad, MD MPH

Recent Guests

Andrea Necchi
Faculty member discussing bladder cancer management
IRCCS St. Raphael Hospital, Milan
Episode: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Shilpa Gupta
Faculty member discussing bladder preservation and treatment options
Tulsa Cancer Institute, Cleveland
Episode: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Dr. Karim Fizazi
Oncologist discussing AKT inhibition and PTEN loss in prostate cancer
Centre Oscar Lambret, Lille, France
Episode: AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Dr. Dan George
Oncologist contributing to the discussion on trial designs and clinical strategies
Duke Cancer Institute, Durham, North Carolina
Episode: AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Dr. Neeraj Agarwal
Presenter of pre-recorded video cases and involved in audience questions
Huntsman Cancer Institute, Salt Lake City, Utah
Episode: AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Dr. Rana McKay
Discussant providing clinical case insights and questions
Moores Cancer Center, San Diego, California
Episode: AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Dr. Elisabeth Heath
Moderator from Mayo Clinic
Mayo Clinic
Episode: AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Rahul Aggarwal
From UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
Episode: Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Matt Galsky
From Mount Sinai Tish Cancer Center
Mount Sinai
Episode: Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

Hosts

Dr. Neil Love
Host of the show, medical oncologist guiding the interview
Elisabeth Heath
Moderator of the session
Terence Friedlander
Moderator and physician providing clinical perspective on bladder cancer therapies (UCSF affiliation appears in records)

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#157
Israel/Science
Apple Podcasts
#245
South Korea/Science

Talking Points

Recent interactions between the hosts and their guests.

AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Q: What was the key signal that AKT inhibition is biologically meaningful?
The discussions highlighted robust signals in patients with PTEN loss showing enhanced responses and potential survival benefits when AKT inhibition is combined with standard therapies, supporting the biology of AKT pathway dependence in this subset.
For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Q: Is one perioperative regimen better than the other, and how should nurses counsel patients?
The choice depends on patient-specific factors such as cisplatin eligibility, kidney function, neuropathy risk, and tumor characteristics; both regimens have distinct toxicity profiles, so counseling should emphasize side effects, monitoring needs, and shared decision-making based on patient priorities.
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Q: Given the toxicity signals with combination regimens, how do you balance upfront toxicity with long-term benefit?
The panel discusses weighing higher early toxicity against potential long-term benefits, with emphasis on selecting patients carefully, optimizing dosing cycles, and considering alternative sequences like monotherapy or different targeted approaches when toxicity risks rise.
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Q: Dan, what were your highlights of the year?
Dr. Petrylak points to EV Pembrolizumab studies opening new treatment frontiers for cisplatin-eligible and ineligible patients, the dramatic improvements in complete response rates, median survival, and the potential of ctDNA to guide adjuvant decisions.
Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Q: How does ctDNA positivity compare to PSA in guiding decisions for bladder cancer, and what are the practical implications for adjuvant therapy?
ctDNA provides a real-time, dynamic risk assessment that complements imaging. While PSA has long guided prostate cancer decisions, ctDNA offers a similar, time-sensitive signal in bladder cancer, enabling you to identify high-risk patients who may benefit from adjuvant immunotherapy and avoid overtreating those at low risk.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Prostate Cancer Update

What is Prostate Cancer Update about and what kind of topics does it cover?

This series pulls from leading prostate cancer researchers and clinicians to translate cutting-edge research into practical insight for patient care. Episodes cover treatment strategies across the disease spectrum—from androgen-deprivation therapies and novel hormonal agents to chemotherapy, radiopharmaceuticals, and emerging biomarker-driven approaches like ctDNA. Hosts guide tight, clinician-to-clinician discussions that blend trial data, real-world experience, safety considerations, and patient-centered decision making, with an emphasis on sequencing, toxicity management, and shared decision making in everyday practice. Noteworthy aspects include a strong focus on integrating translational findings into clinical pathways, multidisciplina... more

Where can I find podcast stats for Prostate Cancer Update?

Rephonic provides a wide range of podcast stats for Prostate Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Prostate Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Prostate Cancer Update get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Prostate Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Prostate Cancer Update?

Rephonic provides comprehensive predictive audience data for Prostate Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Prostate Cancer Update have?

To see how many followers or subscribers Prostate Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Prostate Cancer Update?

These podcasts share a similar audience with Prostate Cancer Update:

1. Gastrointestinal Cancer Update
2. Two Onc Docs
3. Lung Cancer Update
4. Plenary Session
5. Breast Cancer Update

How many episodes of Prostate Cancer Update are there?

Prostate Cancer Update launched 20 years ago and published 178 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Prostate Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Prostate Cancer Update?

Rephonic pulls ratings and reviews for Prostate Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Prostate Cancer Update?

Rephonic provides full transcripts for episodes of Prostate Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Prostate Cancer Update?

Recent guests on Prostate Cancer Update include:

1. Andrea Necchi
2. Shilpa Gupta
3. Dr. Karim Fizazi
4. Dr. Dan George
5. Dr. Neeraj Agarwal
6. Dr. Rana McKay
7. Dr. Elisabeth Heath
8. Rahul Aggarwal

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days